Pacific Meditech Private Limited
About Pacific Meditech Private Limited
Data last updated:
Pacific Meditech Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 December 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2007PTC171412. Its GSTIN is 07AALCS9932R1Z9 (Delhi).
The company has an authorised share capital of ₹9 Lakh and a paid-up capital of ₹6.65 Lakh. It was formerly known as Sun Meditech Private Limited. It is led by directors Chetan Aggarwal and Mayank Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No.2 2nd Floor S – 67 Badli Industrial Area – I Badli, Delhi, India – 110042.
As per the financials filed for FY 2024, the company reported a revenue of ₹10 Cr, a decline of 21% compared to the previous year. For the same year it recorded a net profit of ₹5.35 Lakh (net margin 0.5%) and EBITDA of ₹7.85 Lakh (EBITDA margin 0.8%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 7% over five years.
Court records list 5 cases involving the company, including 4 filed against it; 5 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressOffice No.2 2nd Floor S – 67 Badli Industrial Area – I Badli, Delhi, India – 110042
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pacific Meditech Private Limited
The main business activity of Pacific Meditech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pacific Meditech Private Limited FY 2025 filings available
Pacific Meditech Private Limited reported revenue of ₹10 Cr (down 21% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Pacific Meditech Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 21% fall in the latest year. EBITDA fell 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pacific Meditech Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.85 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.35 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pacific Meditech Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pacific Meditech are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pacific Meditech Private Limited
Pacific Meditech Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Millennium Medicare Private Limited | ₹10.02 Cr (FY 2025) | •••• | •••• | -30.0% | •••• | Gurgaon, Haryana, India |
| Kash Logistics Private Limited | ₹10.02 Cr (FY 2024) | •••• | •••• | -31.0% | •••• | New Delhi, Delhi, India |
| Millionaire Health Private Limited | ₹10.02 Cr (FY 2025) | •••• | •••• | 203.0% | •••• | Delhi, India |
| Fortessa Pharma Private Limited | ₹10.01 Cr (FY 2024) | •••• | •••• | 111.0% | •••• | Pune, Maharashtra, India |
| Uniserve Distributors Private Limited | ₹10.01 Cr (FY 2023) | •••• | •••• | 11.0% | •••• | Kollam, Kerala, India |
| Pacific Meditech Private Limited this company | ₹10 Cr (FY 2024) | •••• | •••• | -21.0% | •••• | Delhi, India |
| Try Bird Healthcare Private Limited | ₹10 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Chandigarh, India |
| Civanta Distributors Private Limited | ₹10 Cr (FY 2024) | •••• | •••• | 3355.0% | •••• | Ahmedabad, Gujarat, India |
| Arogya Niketan Pvt Ltd | ₹9.99 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Hooghly, West Bengal, India |
| N B Marketing Private Limited | ₹9.98 Cr (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Europa Biocare Private Limited | ₹9.98 Cr (FY 2025) | •••• | •••• | 563.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Pacific Meditech by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Pacific Meditech Private Limited
Pacific Meditech Private Limited is audited by J D A & COMPANY for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| J D A & COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Pacific Meditech Private Limited
Pacific Meditech has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chetan Aggarwal | Director | 09 Jun 2020 | 6 Years 4 Months | Current |
| Mayank Aggarwal | Director | 09 Jun 2020 | 6 Years 4 Months | Current |
Ownership and Shareholding of Pacific Meditech Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pacific Meditech Private Limited
Pacific Meditech Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Pacific Meditech Private Limited
Pacific Meditech Private Limited has 5 court cases on record: 4 filed against it, 1 where it is another party. All cases are pending. Status as checked between 30 Sep 2026 and 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 4 | 4 |
| District courts | 1 | 0 | 1 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Franco-Indian Pharmaceuticals Private Limited | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company by Franco-Indian Pharmaceuticals Private Limited | Pending |
| Bombay High Court | Court case (CRR) | Filed against the company by Franco-Indian Pharmaceuticals Private Limited | Pending |
| District court, Kathua, Jammu and Kashmir | Court case (Complaint - Criminal Complaint) | Company is another party | Pending |
Full case history
All 5 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Pacific Meditech Private Limited
Employment history and EPFO contributions of people linked to Pacific Meditech.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pacific Meditech Private Limited
Pacific Meditech Private Limited has 10 board changes on record since 2009: 2 appointments and 8 cessations. The latest: Chetan Aggarwal ceased to be Director on 30 Dec 2020.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Pacific Meditech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pacific Meditech Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pacific Meditech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pacific Meditech Private Limited
Pacific Meditech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AALCS9932R1Z9 | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pacific Meditech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pacific Meditech Private Limited
Pacific Meditech is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 December 2007 (19+ years old) and is registered under CIN U24233DL2007PTC171412.
Pacific Meditech reported revenue of ₹10 Cr for FY 2024 (down 21% YoY).
Pacific Meditech has 2 current directors:
- Chetan Aggarwal - Director
- Mayank Aggarwal - Director
Pacific Meditech reported a net profit of ₹5.35 Lakh (net margin 0.5%) and EBITDA of ₹7.85 Lakh (EBITDA margin 0.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pacific Meditech is -13% over three years and -7% over five years. In the latest year (FY 2024) revenue fell 21%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pacific Meditech is 07AALCS9932R1Z9, registered in Delhi.
The CIN (Corporate Identification Number) of Pacific Meditech is U24233DL2007PTC171412. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pacific Meditech has 5 court cases on record: 4 filed against it. 5 are pending. Most are in the high courts.
Pacific Meditech was incorporated on 13 December 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Pacific Meditech by revenue are Millennium Medicare Private Limited, Kash Logistics Private Limited, Millionaire Health Private Limited, Fortessa Pharma Private Limited, Uniserve Distributors Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Chetan Aggarwal ceased to be Director on 30 Dec 2020. Mayank Aggarwal ceased to be Director on 30 Dec 2020. Ajay Mittal ceased to be Director on 26 Oct 2020. Pacific Meditech has 10 board changes on record in total.